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ABSTRACT 
 
   Lymphoepithelioma rarely develops in children. In its early stage it may manifest itself only as en-
larged cervical lymph nodes, which is likely to cause difficulties in the initial diagnosis. Radiotherapy 
is the treatment of choice, however, chemotherapy has also been used. The paper describes three 
cases of children treated for lymphoepithelioma at the Department of Children Hematology and 
Oncology in Lublin between 1991 - 2001. in all cases, the diagnosis was based on histopathological 
examinations of the tumour or lymph node biopsies. The methods of treatment used were different 
in each case and the longest disease free survival was 3 years. Therefore it seems necessary 
to design a uniform protocol of treatment for children with lymphoepithelioma.  
The first child was treated only to radiotherapy. This choice was based on lack of results of well 
conducted trials of cytostatic treatment. The good result of our treatment confirmed the data presented 
by other with the use of radiotherapy alone. 
In the second case, in case of large tumour, paralysis of cranial nerves, this patient was refered 
to combined treatment (radio-chemotherapy). In this case the partial remission was achived. 
In the third case, chemotherapy (cisplatin + 5-fluorouracil) resulted in perfect remission of the primary 
tumour and metastases to the lymph nodes while radiotherapy allow to achive complete control 
of the primary tumour and metastases to lymph nodes.  
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INTRODUCTION 
 
   Lymphoepithelioma is a rare childhood 
tumour originating from the transitional 
epithelium of the nasopharynx. Its first 
clinical sign is the enlargement of the cer-
vical lymph nodes. The other signs and 
symptoms include: bleeding from the no-
se, sore throat, difficulties in swallowing, 
hypoacusia. The cranial basis infiltration 
results in the paralysis of the cranial 
nerves and severe pain [1]. Due to high 
radiosensitivity, radiotherapy is the treat-
ment of choice, however, chemotherapy 
has also been undertaken [2]. 
 
CASE REPORTS 
 
   The paper presents three cases of chil-
dren treated for lymphoepithelioma at our 
department between 1991 - 2001. 
   Case report I. A 15-year-old boy was 
referred to the department in September 
1991 because of gradually enlarging 
cervical lymph nodes on the left side, 
weight loss and trismus. The laboratory 
tests revealed: high SR (65/100), mild 
anaemia, leucocytosis with neutrophilia. 
The CT scan of the nasopharyngeal cavity 
showed an abnormal tissue mass filling 
the left palatopharyngeal space. The histo-
pathological findings of the tumour’s 
biopsy confirmed lymphoepithelioma. 
Radiotherapy of the nasopharyngeal cavity 
and enlarged lymph nodes was used 
(50 Gy), which resulted in complete 
regression of the proliferative disease. 
The boy was followed-up in the Onco-
logical Outpatient Clinic for 3 years and 
showed total remission. 
   Case report II. An 8-year-old girl was 
admitted to the Department in December 
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1995 because of dropping of the left upper 
eyelid, vision disorders and massive 
bleeding from the nose. The laboratory 
tests did not reveal any abnormalities. 
The CT scan of the head visualized a giant 
mass filling the whole nasopharyngeal 
cavity, which penetrated the final conus 
of the left orbit. The histopathological 
findings showed the features of lympho-
epithelioma. Chemotherapy (Epirubicin 
+ Cisplatin) and radiotherapy (56 Gy) were 
used. After the fifth cycle, the left eyelid 
dropping subsided and MRI revealed 
partial regression of the tumour. The girl 
was qualified for surgery once the peri-
pheral blood parameters have become 
normal. However, after two weeks the pa-
tient was again admitted to the Depart-
ment because of a rapidly growing tumour 
located in the lateral-anterior surface 
of the right shank. The CT scan showed 
the 5.7 x 2.3 cm tumour in the soft tissues 
of the right fibula. The chest X-ray re-
vealed the metastases in the right lung. 
Chemotherapy was changed to BEC 
(Bleomycin, Epirubicin, Cisplatin) and then 
to MEV (Methotrexate, Cyclofosfamid, 
Vincristine). Moreover, the lung (10 Gy) 
and right shank (50 Gy) radiotherapy was 
instituted. The pulmonary lesions re-
gressed while the tumour of the right 
shank increased. Additionally, dissemi-
nation of the inguinal lymph nodes was 
observed. The girl was subjected to pa-
lliative treatment and died due to progre-
ssion of the disease. 
 
   Case report III. A 14-year-old boy was 
referred to the Department because 
of bilaterally enlarged cervical lymph 
nodes. The laboratory tests showed 
no abnormalities. MRI revealed a tumour 
of the nasopharyngeal cavity and the hi-
stopathological findings confirmed lympho-
epithelioma. The patient was subjected 
to chemotherapy (4 cycles of Cisplatin 
+ 5-Fluorouracil) and radiotherapy 
of the nasopharyngeal cavity and cervical 
lymph nodes (56 Gy) and total regression 
of the tumour and metastatic lesions was 
achieved. The boy has been followed–up 
for three months now and total clinical 
and radiological remission has been ob-
served. 
   DISCUSSION 
   Carcinomas of the nasopharyngeal 
cavity constitute less than 1% of childhood 
malignant tumours, which is, however, 
1/3 of the nasopharyngeal tumours [3]. 
The majority of nasopharyngeal tumours 
in children belong to the non-differentiated 
group and their development is related 
to the Epstein-Barr (EBV) infection [4,5]. 
At present, the tumours previously des-
cribed as lymphoepithelioma are diagno-
sed as poorly differentiated epithelial 
carcinomas. The clinical manifestations, 
ways of spreading and prognosis are 
similar in children and adults [6]. 
   The primary tumour of the naso-
pharyngeal cavity may be latent and the 
disease manifests itself only in enlarged 
cervical lymph nodes, which leads to initial 
diagnostic difficulties [1]. Prior to surgery 
of the nasopharyngeal cavity, the lymph 
node biopsy is indicated [7]. Spreading 
of the tumour other than to the lymph 
nodes is likely to develop as spreading 
through the continuity to the cranial basis 
with the accompanying symptoms [8]. 
The remote metastases on diagnosis are 
observed in less than 5% of cases and 
may develop in the lungs, mediastinum, 
bones and liver [9]. Therefore, the initial 
evaluation should include CT/MRI 
of the head, neck and abdominal cavity, 
bone X-ray and scintigraphy. If the cranial 
basis infiltration is detected, the lumbar 
puncture should be performed. The meta-
stases to the bone marrow are rare [10]. 
The differential diagnosis should consider 
angiofibroma of the nasopharyngesal 
cavity and rhabdomyosarcoma [11]. 
   The main treatment method in lympho-
epithelioma is radiotherapy [2]. Operative 
procedures provide only the diagnostic 
material from the tumour or lymph nodes 
or enable to resect the residual lesion left 
after radiotherapy. The recommended 
doses in primary tumours are 50 Gy (small 
tumours in younger children) to 60 Gy (big 
tumours infiltrating the cranial basis in ol-
der children) [12]. However, since radio-
therapy does not provide perfect control, 
the studies on the effectiveness of chemo-
therapeutic agents are carried out. 
The drugs used include: Cisplatin, 
Vincristine, Methotrexate, Bleomycin, 
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Adriamycin, 5-Fluorouracil, Mitomycin C 
[13,14,15]. 
   The first child described was subjected 
only to radiotherapy. This choice was 
based on good results of this management 
in localized tumours and lack of ex-
perience in cytostatic treatment (the boy 
was treated over 10 years ago). The thera-
peutic outcome confirmed the data pre-
sented by other authors concerning 
the use of radiotherapy alone. 
   In the second patient, the features 
of poor prognosis were already observed 
on diagnosis (a big tumour, paralysis 
of the oculomotor nerve). Therefore 
the patient was subjected to combined 
treatment (chemo- and radiotherapy) and 
partial remission of the primary lesion was 
achieved. However, the disease could not 
be stopped when remote metastases 
developed. 
   In the third child, chemotherapy 
(Cisplatin + 5-Fluorouracil) resulted in per-
fect remission of the primary tumour and 
metastases to the lymph nodes while 
radiotherapy (55 Gy) provided good local 
control of the primary tumour and 
metastatic lesions. 
 
CONCLUSIONS 
 
1. Lymphoepithelioma is a rare childhood 
malignant tumour, which, in the majo-
rity of case is diagnosed when the me-
tastases (mainly to the lymph nodes) 
occur. 
2. Sporadic incidence of lymphoepithe-
lioma in children created difficulties 
in finding uniform methods of thera-
peutic management. 
3. It seems that combined treatment 
(chemotherapy, surgery and radio-
therapy) gives chances of long survival 
and recovery, even in advanced 
stages of the disease. 
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